The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury.

Details

Serval ID
serval:BIB_9CA27B5577EF
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury.
Journal
The Journal of clinical investigation
Author(s)
Yasukawa H., Yajima T., Duplain H., Iwatate M., Kido M., Hoshijima M., Weitzman M.D., Nakamura T., Woodard S., Xiong D., Yoshimura A., Chien K.R., Knowlton K.U.
ISSN
0021-9738 (Print)
ISSN-L
0021-9738
Publication state
Published
Issued date
02/2003
Peer-reviewed
Oui
Volume
111
Number
4
Pages
469-478
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Abstract
Enteroviral infections of the heart are among the most commonly identified causes of acute myocarditis in children and adults and have been implicated in dilated cardiomyopathy. Although there is considerable information regarding the cellular immune response in myocarditis, little is known about innate signaling mechanisms within the infected cardiac myocyte that contribute to the host defense against viral infection. Here we show the essential role of Janus kinase (JAK) signaling in cardiac myocyte antiviral defense and a negative role of an intrinsic JAK inhibitor, the suppressor of cytokine signaling (SOCS), in the early disease process. Cardiac myocyte-specific transgenic expression of SOCS1 inhibited enterovirus-induced signaling of JAK and the signal transducers and activators of transcription (STAT), with accompanying increases in viral replication, cardiomyopathy, and mortality in coxsackievirus-infected mice. Furthermore, the inhibition of SOCS in the cardiac myocyte through adeno-associated virus-mediated (AAV-mediated) expression of a dominant-negative SOCS1 increased the myocyte resistance to the acute cardiac injury caused by enteroviral infection. These results indicate that strategies directed at inhibition of SOCS in the heart and perhaps other organs can augment the host-cell antiviral system, thus preventing viral-mediated end-organ damage during the early stages of infection.
Keywords
Animals, Carrier Proteins/antagonists & inhibitors, Carrier Proteins/genetics, Carrier Proteins/physiology, DNA-Binding Proteins/metabolism, Dependovirus/genetics, Enterovirus B, Human/pathogenicity, Enterovirus B, Human/physiology, Enterovirus Infections/etiology, Enterovirus Infections/physiopathology, Enterovirus Infections/therapy, Genetic Therapy, Humans, Intracellular Signaling Peptides and Proteins, JNK Mitogen-Activated Protein Kinases, Mice, Mice, Inbred BALB C, Mice, Transgenic, Mitogen-Activated Protein Kinases/metabolism, Models, Biological, Myocarditis/etiology, Myocarditis/physiopathology, Myocarditis/therapy, Repressor Proteins, STAT1 Transcription Factor, STAT3 Transcription Factor, Signal Transduction, Suppressor of Cytokine Signaling 1 Protein, Suppressor of Cytokine Signaling Proteins, Trans-Activators/metabolism, Transfection, Virus Replication
Pubmed
Web of science
Open Access
Yes
Create date
25/01/2008 14:44
Last modification date
09/04/2024 7:13
Usage data